Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Vivos Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +8 vs. Q2 2021
- Shares held
- 2.26M
- −83.5K (−3.6%) vs. Q2 2021
- Total value
- $9.14M
- −$2.54M (−21.8%) vs. Q2 2021
- New holders
- 17
- 11 more added
- Sold out
- 9
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $646.8K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.02M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 617,251 | $2.49M | 0.00% | +233,360+60.8% | Added |
| Avalon Investment & Advisory | 329,322 | $1.33M | 0.03% | +139,583+73.6% | Added |
| Bard Associates Inc | 215,500 | $871.0K | 0.29% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 157,324 | $636.0K | 0.00% | +157,324 | New |
| Perkins Capital Management Inc | 146,500 | $592.0K | 0.37% | −16,000−9.8% | Reduced |
| Citadel Advisors LLC | 79,119 | $320.0K | 0.00% | +79,119 | New |
| Geode Capital Management, LLC | 73,851 | $298.0K | 0.00% | +26,190+55.0% | Added |
| Credit Agricole S A | 59,103 | $239.0K | 0.01% | +59,103 | New |
| Susquehanna International Group, LLP | 54,903 | $222.0K | 0.00% | +54,903 | New |
| National Asset Management, Inc. | 50,987 | $206.0K | 0.01% | +16,269+46.9% | Added |
| Griffin Asset Management, Inc. | 49,500 | $200.0K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 48,905 | $198.0K | 0.00% | +35,158+255.8% | Added |
| Boston Partners | 46,651 | $188.0K | 0.00% | +46,651 | New |
| Russell Investments Group, Ltd. | 46,651 | $188.0K | 0.00% | +46,651 | New |
| Northern Trust Corp | 41,027 | $166.0K | 0.00% | +29,544+257.3% | Added |
| Tower Research Capital LLC (TRC) | 37,631 | $152.0K | 0.00% | +37,631 | New |
| Aperture Investors, LLC | 35,276 | $143.0K | 0.02% | +2,665+8.2% | Added |
| Virtu Financial LLC | 35,334 | $143.0K | 0.01% | +35,334 | New |
| Schonfeld Strategic Advisors LLC | 34,443 | $139.0K | 0.00% | +34,443 | New |
| Blueshift Asset Management, LLC | 18,826 | $76.0K | 0.00% | +18,826 | New |
| State Street Corp | 18,233 | $74.0K | 0.00% | +18,233 | New |
| Jane Street Group, LLC | 14,999 | $60.0K | 0.00% | +14,999 | New |
| WMS Partners, LLC | 12,167 | $49.0K | 0.01% | −4,500−27.0% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 12,000 | $48.0K | 0.00% | −25,551−68.0% | Reduced |
| Group One Trading, L.P. | 7,336 | $30.0K | 0.00% | +7,336 | New |
| Financial Management Professionals, Inc. | 5,897 | $24.0K | 0.01% | +2,536+75.5% | Added |
| Rockefeller Capital Management L.P. | 3,500 | $14.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,895 | $12.0K | 0.00% | +555+23.7% | Added |
| Morgan Stanley | 2,530 | $10.0K | 0.00% | +1,055+71.5% | Added |
| Wells Fargo & Company | 2,109 | $8.00K | 0.00% | +2,056+3,879.2% | Added |
| Kozak & Associates, Inc. | 1,205 | $5.00K | 0.00% | +1,205 | New |
| Royal Bank of Canada | 678 | $3.00K | 0.00% | +678 | New |
| Global Retirement Partners, LLC | 570 | $2.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 501 | $2.00K | 0.00% | +501 | New |
| Toth Financial Advisory Corp | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wagner Wealth Management, LLC | 275 | $1.00K | 0.00% | 00.0% | Unchanged |
| Quantbot Technologies LP | 480 | $1.00K | 0.00% | +480 | New |
| Royce & Associates LP | 0 | $0 | 0.00% | −348,000−100.0% | Sold out |
| Penn Capital Management Co Inc | 0 | $0 | 0.00% | −223,403−100.0% | Sold out |
| Archon Capital Management LLC | 0 | $0 | 0.00% | −215,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Millrace Asset Group, Inc. | 0 | $0 | 0.00% | −93,993−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −64,746−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,169−100.0% | Sold out |
| IHT Wealth Management, LLC | 0 | $0 | 0.00% | −12,330−100.0% | Sold out |